deferoxamine has been researched along with lactacystin in 7 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 3 (42.86) | 18.2507 |
2000's | 4 (57.14) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Fernandez, PA; Martinou, I; Martinou, JC; Missotten, M; Sadoul, R | 1 |
Fukuchi, K; Gomi, K; Nakamaki, T; Tomoyasu, S; Tsuruoka, N | 1 |
Fukuchi, K; Gomi, K; Maruyama, H; Takagi, Y | 1 |
Backlund, PS; Bourdon, E; Drake, SK; Levine, RL; Rouault, TA; Wehr, NB; Yergey, AL | 1 |
Caltagirone, A; Chahine, D; Fillebeen, C; Pantopoulos, K; Segal, P | 1 |
Le, W; Pan, T; Qu, S; Wang, X; Xie, W; Zhang, X | 1 |
Bockmühl, U; Fuchs, J; Gross, J; Jahnke, V; Kietzmann, T; Machulik, A | 1 |
7 other study(ies) available for deferoxamine and lactacystin
Article | Year |
---|---|
Bax and Bak proteins require caspase activity to trigger apoptosis in sympathetic neurons.
Topics: Acetylcysteine; Amino Acid Chloromethyl Ketones; Animals; Apoptosis; bcl-2 Homologous Antagonist-Killer Protein; bcl-2-Associated X Protein; Cysteine Endopeptidases; Cysteine Proteinase Inhibitors; Deferoxamine; Membrane Proteins; Nerve Tissue Proteins; Neurons; Phosphodiesterase Inhibitors; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-bcl-2; Rats; Superior Cervical Ganglion | 1998 |
DNA damage induces p21 protein expression by inhibiting ubiquitination in ML-1 cells.
Topics: Acetylcysteine; Cell Nucleus; Cyclin-Dependent Kinase Inhibitor p21; Cyclins; Cysteine Proteinase Inhibitors; Cytarabine; Deferoxamine; DNA Damage; Etoposide; Gene Expression Regulation; Hydroxyurea; Polyribosomes; RNA, Messenger; Tumor Cells, Cultured; Ubiquitins | 1998 |
Direct proteasome inhibition by clasto-lactacystin beta-lactone permits the detection of ubiquitinated p21(waf1) in ML-1 cells.
Topics: Acetylcysteine; Antibodies; Blotting, Western; Cyclin-Dependent Kinase Inhibitor p21; Cyclins; Cysteine Endopeptidases; Deferoxamine; Electrophoresis, Polyacrylamide Gel; Enzyme Inhibitors; Humans; Lactones; Multienzyme Complexes; Proteasome Endopeptidase Complex; Tumor Cells, Cultured; Ubiquitins | 1999 |
Numerous proteins in Mammalian cells are prone to iron-dependent oxidation and proteasomal degradation.
Topics: Acetylcysteine; Blotting, Western; Cysteine Endopeptidases; Cysteine Proteinase Inhibitors; Deferoxamine; Ferric Compounds; Humans; Iron; Iron Chelating Agents; Multienzyme Complexes; Oxidation-Reduction; Proteasome Endopeptidase Complex; Proteins; Quaternary Ammonium Compounds; Tumor Cells, Cultured | 2002 |
A phosphomimetic mutation at Ser-138 renders iron regulatory protein 1 sensitive to iron-dependent degradation.
Topics: Acetylcysteine; Amino Acid Sequence; Animals; Cell Line; Cysteine Proteinase Inhibitors; Deferoxamine; Humans; Iron; Iron Chelating Agents; Iron Regulatory Protein 1; Leupeptins; Mice; Molecular Sequence Data; Mutation; Point Mutation; Recombinant Proteins; Sequence Homology, Amino Acid; Serine | 2003 |
Neuroprotection by iron chelator against proteasome inhibitor-induced nigral degeneration.
Topics: Acetylcysteine; Animals; Deferoxamine; Iron Chelating Agents; Male; Mice; Mice, Inbred C57BL; Nerve Degeneration; Neuroprotective Agents; Parkinsonian Disorders; Proteasome Inhibitors; Substantia Nigra; Treatment Outcome; Ubiquitin | 2005 |
Apoptosis, necrosis and hypoxia inducible factor-1 in human head and neck squamous cell carcinoma cultures.
Topics: Acetylcysteine; Apoptosis; Carcinoma, Squamous Cell; Cell Hypoxia; Cell Line, Tumor; Cell Nucleus; Cell Shape; Cobalt; Deferoxamine; DNA-Binding Proteins; Flow Cytometry; Gene Expression Regulation, Neoplastic; Head and Neck Neoplasms; Humans; Hypoxia-Inducible Factor 1; Hypoxia-Inducible Factor 1, alpha Subunit; Immunohistochemistry; Necrosis; Nuclear Proteins; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Time Factors; Transcription Factors | 2005 |